These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 35228800)

  • 1. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
    Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
    Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
    Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
    J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
    Wang B; Yu XC; Xu SF; Xu M
    J Nanobiotechnology; 2015 Mar; 13():22. PubMed ID: 25880868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E; Park J; Yeo Y
    Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination nanochemotherapy of brain tumor using polymeric nanoparticles loaded with doxorubicin and paclitaxel: An in vitro and in vivo study.
    Malekpour MR; Hosseindoost S; Madani F; Kamali M; Khosravani M; Adabi M
    Eur J Pharm Biopharm; 2023 Dec; 193():175-186. PubMed ID: 37926270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
    Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.